Seven of the Best Investments You Could Have Made in 2014

Joel Anderson | |

Christmas comes but once a year, but a portfolio with huge returns is the gift that just keeps on giving. That’s why we’re taking the end of the year to look back at those investments

Infinity Pharmaceuticals (INFI) Deal with AbbVie (ABBV) Boosts TG Therapeutics (TGTX) Stock

Joel Anderson | |

Stock in TG Therapeutics (TGTX) popped in Wednesday trading, seeing shares bounce 9.11%. Driving the gains appears to be the favorable deal secured by rival Infinity (INFI) with AbbVie (ABBV)

King: How the Oncology Drug Development Machine Builds Biotech Wealth

The Life Sciences Report | |

Veteran biotechnology analyst Michael King of JMP Securities has seen drug development evolve from hit-or-miss to the sophisticated, high-throughput discovery techniques in place today. He

Are Exchange Traded Funds Becoming Too Risky?

Michael Teague | |

Since their introduction over the past decade, Exchange Traded Funds (ETFs) have quickly established themselves as a standard and highly sought-after financial instrument for investors.ETFs are

Sponsored Financial Content

Market Movers